With NIH funding, the group will pursue research and patient care approaches for a disease that affects more than 250 million people around the globe ...
The introduction of highly effective direct-acting antivirals has transformed the HCV treatment landscape, enabling cure ...
The Johns Hopkins Medicine-led, multinational Hepatitis B and HIV Cure Consortium, colloquially known as the BICC, was recently established through ...
The World Health Organization (WHO) released landmark Consolidated guidance and implementation handbook on hepatitis B and C , to support countries ...
A case of a 45-year-old construction worker with a history of intravenous drug use, homelessness, and occasional alcohol and tobacco use.
“Large-scale efforts need to be made" in the fight against these cancers, said paper author Dr. Ju Dong Yang.
Transmission electron micrograph showing hepatitis B virus particles (colored orange). The Johns Hopkins Medicine-led ...
Hepatitis B virus (HBV) infection remains an urgent global health concern, affecting hundreds of millions of people and significantly heightening the risk of severe liver complications, including ...
Live Science spoke with the scientists behind an upcoming clinical trial testing an immune therapy for depression.
The report said the increase represented a major improvement from 29 per cent recorded in 2023, driven by intensified case finding, improved linkage to care and treatment optimisation.
Hepatitis B is one of the most widespread viral infections in the world, with hundreds of millions of people living with it today. Caused by the hepatitis B virus (HBV), this condition primarily ...
Atea Pharmaceuticals, Inc. (NASDAQ:AVIR) Q4 2025 Earnings Call Transcript March 5, 2026 Atea Pharmaceuticals, Inc. misses on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results